{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:58:08Z","timestamp":1740135488402,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"ABBVIE Farmac\u00e9utica S.L.U.","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>ProSeal (PLMA) and Supreme (SLMA) laryngeal mask airways are effective ventilator devices with distinctive designs that may require different anaesthetics for insertion. Sevoflurane induction provides acceptable conditions for laryngeal mask insertion, and remifentanil significantly decreases the minimum alveolar concentration of sevoflurane required for that insertion. The study aimed to evaluate the optimal end-tidal (ET) sevoflurane concentration for successful insertion of PLMA versus SLMA in patients receiving a remifentanil infusion without a neuromuscular blocking agent.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Altogether, 45 patients ASA (American Society Anaesthesiologists) physical status I\u2013II, aged 18\u201360\u2009years were scheduled for elective ambulatory surgery. Exclusion criteria were a difficult airway, recent respiratory infection, reactive airway, obstructive sleep apnoea syndrome, gastric aspiration\u2019s risk factors, pregnancy, and lactation. Patients were randomly allocated to receive the SLMA or the PLMA. Sevoflurane induction with co-administration of remifentanil was performed at an effect-site concentration of 4\u2009ng\u2009mL<jats:sup>\u2212\u20091<\/jats:sup>. ET<jats:sub>50<\/jats:sub> was calculated with a modified Dixon\u2019s up-and-down method (starting at 2.5% in steps of 0.5%). Predetermined sevoflurane concentration was kept constant during the 10\u2009min before LMA insertion. Patient\u2019s response to LMA insertion was classified as \u201cmovement\u201d or \u201cno movement\u201d. Sevoflurane ET<jats:sub>50<\/jats:sub> was determined as the midpoint concentration of all the independent pairs that manifested crossover from \u201cmovement\u201d to \u201cno movement\u201d.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The ET<jats:sub>50<\/jats:sub> sevoflurane concentration co-administered with remifentanil required for PLMA insertion was 1.20\u2009\u00b1\u20090.41% (95% confidence interval 0.76 to 1.63%). For SLMA insertion, it was 0.55\u2009\u00b1\u20090.38% (95% confidence interval 0.14 to 0.95%) (<jats:italic>p<\/jats:italic>\u00a0=\u20090.019).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The end-tidal sevoflurane concentration with co-administered remifentanil required to allow insertion of the SLMA was 54% lower than that needed for inserting the PLMA.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Trial registration<\/jats:title>\n<jats:p>Clinicaltrials.gov identifier: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03003377\">NCT03003377<\/jats:ext-link>. Retrospectively registered. Date of registration: December 28, 2016.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12871-019-0921-5","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T08:03:18Z","timestamp":1578384198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Supreme\u2122 laryngeal mask airway insertion requires a lower concentration of sevoflurane than ProSeal\u2122 laryngeal mask airway insertion during target-controlled remifentanil infusion: a prospective randomised controlled study"],"prefix":"10.1186","volume":"20","author":[{"given":"Cristina","family":"Monteser\u00edn-Matesanz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Anad\u00f3n-Baselga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1398-8965","authenticated-orcid":false,"given":"Matilde","family":"Zaballos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,7]]},"reference":[{"key":"921_CR1","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/BF03016565","volume":"52","author":"TM Cook","year":"2005","unstructured":"Cook TM, Lee G, Nolan JP. The proseal\u2122laryngeal mask airway: a review of the literature. Can J Anaesth. 2005;52:739\u201360.","journal-title":"Can J Anaesth"},{"key":"921_CR2","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1365-2044.2008.05824.x","volume":"64","author":"TM Cook","year":"2009","unstructured":"Cook TM, Gatward JJ, Handel J, et al. Evaluation of the LMA supreme\u2122 in 100 non-paralysed patients. Anaesthesia. 2009;64:555\u201362.","journal-title":"Anaesthesia"},{"key":"921_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/bja\/aeh032","volume":"92","author":"M Kodaka","year":"2004","unstructured":"Kodaka M, Okamoto Y, Koyama K, et al. Predicted values of propofol EC50 and sevoflurane concentration for insertion of laryngeal mask classic and ProSeal. Br J Anaesth. 2004;92:242\u20135.","journal-title":"Br J Anaesth"},{"key":"921_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/EJA.0b013e32835c5512","volume":"30","author":"M Zaballos","year":"2013","unstructured":"Zaballos M, Bastida E, Jim\u00e9nez C, et al. Predicted end-tidal sevoflurane concentration for insertion of a laryngeal mask supreme. Eur J Anaesthesiol. 2013;30:170\u20134.","journal-title":"Eur J Anaesthesiol"},{"key":"921_CR5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/00003643-200205000-00010","volume":"19","author":"SB Ganatra","year":"2002","unstructured":"Ganatra SB. D\u2019Mello J, Butani M et al. conditions for insertion of the laryngeal mask airway: comparisons between sevoflurane and propofol using fentanyl as a co-induction agent. A pilot study. Eur J Anaesthesiol. 2002;19:371\u20135.","journal-title":"Eur J Anaesthesiol"},{"key":"921_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1046\/j.1365-2044.1999.00663.x","volume":"54","author":"P Sivalingam","year":"1999","unstructured":"Sivalingam P, Kandasamy R, Madhavan G, et al. Conditions for laryngeal mask insertion. A comparison of propofol versus sevoflurane with or without alfentanil. Anaesthesia. 1999;54:271\u20136.","journal-title":"Anaesthesia"},{"key":"921_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/01.EJA.0000435015.89651.3d","volume":"31","author":"S Maitra","year":"2014","unstructured":"Maitra S, Khanna P, Baidya DK. Comparison of laryngeal mask airway supreme and laryngeal mask airway pro-seal for controlled ventilation during general anaesthesia in adult patients: systematic review with meta-analysis. Eur J Anaesthesiol. 2014;31:266\u201373.","journal-title":"Eur J Anaesthesiol"},{"key":"921_CR8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/ALN.0b013e3181942c4d","volume":"110","author":"A Timmermann","year":"2009","unstructured":"Timmermann A, Cremer S, Eich C, et al. Prospective clinical and fiberoptic evaluation of the supreme laryngeal mask airway. Anesthesiology. 2009;110:262\u20135.","journal-title":"Anesthesiology"},{"key":"921_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2044.2008.05682.x","volume":"64","author":"S Eschertzhuber","year":"2009","unstructured":"Eschertzhuber S, Brimacombe J, Hohlrieder M, et al. The laryngeal mask airway supreme--a single use laryngeal mask airway with an oesophageal vent. A randomised, cross-over study with the laryngeal mask airway ProSeal in paralysed, anaesthetised patients. Anaesthesia. 2009;64:79\u201383.","journal-title":"Anaesthesia"},{"key":"921_CR10","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1097\/EJA.0b013e32833679e3","volume":"27","author":"E Seet","year":"2010","unstructured":"Seet E, Rajeev S, Firoz T, et al. Safety and efficacy of laryngeal mask airway supreme versus laryngeal mask airway ProSeal: a randomized controlled trial. Eur J Anaesthesiol. 2010;27:602\u20137.","journal-title":"Eur J Anaesthesiol"},{"key":"921_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/00000542-199701000-00005","volume":"86","author":"CF Minto","year":"1997","unstructured":"Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II Model application. Anesthesiology. 1997;86:24\u201333.","journal-title":"Anesthesiology"},{"key":"921_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0149-7634(05)80090-9","volume":"15","author":"WJ Dixon","year":"1991","unstructured":"Dixon WJ. Staircase bioassay: the up-and-down method. Neurosci Biobehav Rev. 1991;15:47\u201350.","journal-title":"Neurosci Biobehav Rev"},{"key":"921_CR13","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/00000542-199609000-00012","volume":"85","author":"M Muzi","year":"1996","unstructured":"Muzi M, Robinson BJ, Ebert TJ, et al. Induction of anesthesia and tracheal intubation with sevoflurane in adults. Anesthesiology. 1996;85:536\u201343.","journal-title":"Anesthesiology"},{"key":"921_CR14","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/00000542-197504000-00003","volume":"42","author":"RH de Jong","year":"1975","unstructured":"de Jong RH, Eger EI. MAC expanded: AD50 and AD95 values of common inhalation anesthetics in man. Anesthesiology. 1975;42:384\u20139.","journal-title":"Anesthesiology"},{"key":"921_CR15","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1097\/00000542-200112000-00014","volume":"95","author":"M Paul","year":"2001","unstructured":"Paul M, Fisher DM. Are estimates of MAC reliable? Anesthesiology. 2001;95:1362\u201370.","journal-title":"Anesthesiology"},{"key":"921_CR16","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1046\/j.1365-2044.2000.01538.x","volume":"55","author":"AM Cros","year":"2000","unstructured":"Cros AM, Lopez C, Kandel T, et al. Determination of sevoflurane alveolar concentration for tracheal intubation with remifentanil, and no muscle relaxant. Anaesthesia. 2000;55:965\u20139.","journal-title":"Anaesthesia"},{"key":"921_CR17","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1177\/147323001204000426","volume":"40","author":"HJ Kwak","year":"2012","unstructured":"Kwak HJ, Chae YJ, Lee KC, et al. Target-controlled infusion of remifentanil for laryngeal mask airway insertion during sevoflurane induction in adults. J Int Med Res. 2012;40:1476\u201382.","journal-title":"J Int Med Res"},{"key":"921_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/0310057X1604400208","volume":"44","author":"B Ghai","year":"2016","unstructured":"Ghai B, Jain K, Bansal D, et al. End-tidal sevoflurane concentration for ProSeal\u2122 versus classic\u2122 laryngeal mask airway insertion in unpremedicated anaesthetized adult females. Anaesth Intensive Care. 2016;44:221\u20136.","journal-title":"Anaesth Intensive Care"},{"key":"921_CR19","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/00000542-200703000-00011","volume":"106","author":"SC Manyam","year":"2007","unstructured":"Manyam SC, Gupta DK, Johnson KB, et al. When is a bispectral index of 60 too low?: rational processed electroencephalographic targets are dependent on the sedative-opioid ratio. Anesthesiology. 2007;106:472\u201383.","journal-title":"Anesthesiology"},{"key":"921_CR20","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/01.anes.0000267514.42592.2a","volume":"107","author":"NL Pace","year":"2007","unstructured":"Pace NL, Stylianou MP. Advances in and limitations of up-and-down methodology: a pr\u00e9cis of clinical use, study design, and dose estimation in anesthesia research. Anesthesiology. 2007;107:144\u201352.","journal-title":"Anesthesiology"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-019-0921-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12871-019-0921-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-019-0921-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:10:46Z","timestamp":1609891846000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-019-0921-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,7]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["921"],"URL":"https:\/\/doi.org\/10.1186\/s12871-019-0921-5","relation":{},"ISSN":["1471-2253"],"issn-type":[{"type":"electronic","value":"1471-2253"}],"subject":[],"published":{"date-parts":[[2020,1,7]]},"assertion":[{"value":"3 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local ethics committee: Ethical Committee code FIBHGM-ECNC002\u20132013, provided by the Ethics Committee of Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain (Chairman Dr. Fernando D\u00edaz Otero) on 12 June 2013. Written informed consent to participate was obtained from all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MZ reports research funding and speaker fees from ABBVIE and Teleflex outside the submitted work. CMM, TG, and MJAB declare no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}